MPP+ decreases store-operated calcium entry and TRPC1 expression in Mesenchymal Stem Cell derived dopaminergic neurons.
MPP+ decreases store-operated calcium entry and TRPC1 expression in Mesenchymal Stem Cell derived dopaminergic neurons.
复制标题
MPP 减少间充质干细胞衍生的多巴胺能神经元中钙库操纵的钙进入和 TRPC1 表达。
DOI:
10.1038/s41598-018-29528-x
复制
发表时间:
2018
影响因子:
4.6
通讯作者:
Ohm,JoyceE
中科院分区:
文献类型:
--
作者:
Sun,Yuyang;Selvaraj,Senthil;Pandey,Sumali;Humphrey,KristenM;Foster,JamesD;Wu,Min;Watt,JohnA;Singh,BrijB;Ohm,JoyceE
Parkinson’s disease is a neurodegenerative disorder involving the progressive loss of dopaminergic neurons (DNs), with currently available therapeutics, such as L-Dopa, only able to relieve some symptoms. Stem cell replacement is an attractive therapeutic option for PD patients, and DNs derived by differentiating patient specific stem cells under definedin-vitroconditions may present a viable opportunity to replace dying neurons. We adopted a previously published approach to differentiate Mesenchymal Stem Cells (MSCs) into DN using a 12-day protocol involving FGF-2, bFGF, SHH ligand and BDNF. While MSC-derived DNs have been characterized for neuronal markers and electrophysiological properties, we investigated store-operated calcium entry (SOCE) mechanisms of these DNs under normal conditions, and upon exposure to environmental neurotoxin, 1-methyl, 4-phenyl pyridinium ion (MPP+). Overall, we show that MSC-derived DNs are functional with regard to SOCE mechanisms, and MPP+exposure dysregulates calcium signaling, making them vulnerable to neurodegeneration. Sincein-vitrodifferentiation of MSCs into DNs is an important vehicle for PD disease modeling and regenerative medicine, the results of this study may help with understanding of the pathological mechanisms underlying PD.